Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.82 |
| ▸ | TSHR | P16473 | 2/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.82 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.71 |
| ▸ | PGR | P06401 | 1/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.71 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.71 |
| ▸ | MGLL | Q99685 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | CNR1 | P21554 | 1/20 | 0.66 |
| ▸ | F7 | P08709 | 4/20 | 0.65 |
| ▸ | F3 | P13726 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | PPARG | P37231 | 3/20 | 0.65 |
| ▸ | PPARD | Q03181 | 3/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3046418 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| Ethyl Linoleate SCHEMBL81540 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL3046420 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| Ethyl Linoleate SCHEMBL15469171 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL8982666 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| Ethyl Linoleate SCHEMBL2019418 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL6808633 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL6808635 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL6808235 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL31264381 | 1.00 | ALDH1A1 (0.82) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107664664-B | Method for simultaneously detecting 4-class ethanol non-oxidized metabolites in human whole blood | 复旦大学 | 2020-09-01 | — | — | CN | claimed |
| US-10668122-B2 | Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic disease, the preparation method and the use thereof | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2020-06-02 | — | — | US | claimed |
| US-20170252393-A1 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASE, THE PREPARATION METHOD AND THE USE THEREOF | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2017-09-07 | — | — | US | claimed |
| EP-2519244-A1 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF | Kaohsiung Medical University (TW) | 2012-11-07 | — | — | EP | claimed |
| WO-2011082148-A1 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2011-07-07 | — | — | WO | claimed |
| US-20110159127-A1 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2011-06-30 | — | — | US | claimed |
| EP-4720051-A1 | IONIZABLE LIPIDS | Bristol-Myers Squibb Company (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024243480-A1 | IONIZABLE LIPIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240390284-A1 | IONIZABLE LIPIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-11-28 | — | — | US | disclosed |
| CN-115684392-A | Detection technology for rapidly and effectively identifying white spirit brewed by solid-state method | 北京工商大学 | 2023-02-03 | — | — | CN | disclosed |
| US-10668122-B2 | Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic disease, the preparation method and the use thereof | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2020-06-02 | — | — | US | disclosed |
| US-9902837-B2 | Oil extended functionalized styrene-butadiene copolymer | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-02-27 | — | — | US | disclosed |
| US-20170252393-A1 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASE, THE PREPARATION METHOD AND THE USE THEREOF | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2017-09-07 | — | — | US | disclosed |
| US-4292214-A | LIGNIN-CELLULOSE EPOXY RESIN, POLYISOCYANATE | BLOUNT DAVID H | 1981-09-29 | — | — | US | disclosed |
| US-4292413-A | Process for the production of epoxy cellular solid products | BLOUNT DAVID H | 1981-09-29 | — | — | US | disclosed |
| US-4235974-A | Process for the production of epoxy cellular solid products | BLOUNT DAVID H | 1980-11-25 | — | — | US | disclosed |
| EP-0014745-A1 | Curing agent for polyepoxides, curable epoxy resin compositions, hardened products therefrom and process for curing a polyepoxide | DIAMOND SHAMROCK CORPORATION (US) | 1980-09-03 | — | — | EP | disclosed |
| US-4177173-A | INFUSIBLE FILMS, CASTINGS OR ADHESIVES | DIAMOND SHAMROCK CORPORATION (US) | 1979-12-04 | — | — | US | disclosed |
| US-4065316-A | EPOXY RESIN, METHYLATED AMINO RESIN AND PIGMENT | WESTERN ELECTRIC COMPANY, INCORPORATED (US) | 1977-12-27 | — | — | US | disclosed |
| US-4034014-A | FROM MALEIC MONOMERS AND ALKYLSTYRENES | ALLIED CHEMICAL CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240390284-A1 | IONIZABLE LIPIDS | NPC1L1, ABCB4, NPC1 | ALDH1A1 4680/4885CYP3A4 4671/4885ALOX15 2847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.